Paralysis

Lawsuit Funding Leader Launches New Page for Pharmaceutical Bad Drug Lawsuits

Retrieved on: 
목요일, 5월 2, 2024
Stroke, Suicidal ideation, Effectiveness, Long-term care, Lawsuit, Tremor, Paralysis, Lawyer, Pharmaceutical industry

NEW BRUNSWICK, N.J., May 2, 2024 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Pre-Settlement and Settlement Funding Company, announced today that they have brought on additional staff and launched a new website specifically designed to assist plaintiffs with different types of suits against big pharma and pharmaceutical companies, whether that claim is for a bad drug, defective med, or defective or malfunctioning product.

Key Points: 
  • Due to the high volume of lawsuit loan requests received on a daily basis for different personal injury type claims, with claims mounting in the big pharma sphere, Legal-Bay decided to build a niche lawsuit funding program specifically for big pharma claims and bad drug lawsuits and defective meds suits.
  • Our team is equipped to guide them in the right direction, whether they are looking for a lawyer on a specific bad drug, need cash advance lawsuit funding, or surgical funding for something that went wrong from a drug they took.
  • In any of those cases, we feel we are the best lawsuit funding company out there to help victims of bad drugs in their time of need get the funding they deserve.
  • Bad drug litigations are changing all the time, so to learn more about the various ways the lawsuit settlement loan company can help you with your specific drug questions or bad drug claim, please visit our site, at: https://lawsuitssettlementfunding.com/pharmaceutical-drug.php
    The personalized lawsuit loan funds—commonly referred to as lawsuit loans, loan on lawsuit, lawsuit settlement loans, loans for settlement, loan on lawsuit settlements, or law suit loans—are risk-free, meaning you only have to pay back the lawsuit money if and when you win your case.

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

Retrieved on: 
목요일, 4월 25, 2024
FDA, De novo, Partnership, EUR, TAP, Spinal cord, Lead, BDD, Defense, American Academy, Class, MJFF, Equity, Safety, ARC, BCI, Euronext, Research, University, Hemiunu, Global marketing, Government, SCI, Nature Medicine, Paralysis, Movement, SDVOSB, Pharmaceutical industry

The Company is developing a portfolio of ARC-IM Leads, each optimized for placement on a different area of the spinal cord.

Key Points: 
  • The Company is developing a portfolio of ARC-IM Leads, each optimized for placement on a different area of the spinal cord.
  • Also in November, ONWARD Medical research partner .NeuroRestore was awarded a $1 million grant from The Michael J.
  • In Q2, Bryan, Garnier & Co reinitiated research coverage of ONWARD Medical following the appointment of a new equity research analyst.
  • For 2023, the Company reported an operating loss of EUR 35.5M compared to EUR 32.0M in 2022.

Endowment fund helps undergraduates explore career opportunities

Retrieved on: 
금요일, 4월 19, 2024
University, Biomedical engineering, Angelos, Fear, University of Miami, Building, Trauma, Entrepreneurship, Communication, Parent, Photography, Mark, Paralysis, NASCAR, Culture, Creative Artists Agency, Family, Campaign, Century, MD Anderson Cancer Center, Port, Student, Tourism

CORAL GABLES, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Internships play a crucial role in an undergraduate’s academic career.

Key Points: 
  • CORAL GABLES, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Internships play a crucial role in an undergraduate’s academic career.
  • From gaining invaluable hands-on experience to networking with professionals in their prospective industry, an internship is beneficial—whether paid or unpaid.
  • Mark and Maureen Angelo share that belief and a deep affection for the University of Miami, which led them to make a $1 million gift to the Toppel Career Center .
  • Through the Mark and Maureen Angelo Family Endowment Fund , which has also received support from other parents of University of Miami students, undergraduate students can receive financial awards as they pursue high quality internships that foster their career exploration.

Behr Paint Company Announces 2024 Exterior Stain Colour of the Year, “Tugboat,” Part of its New Curb Appeal Collection

Retrieved on: 
화요일, 4월 16, 2024
Tugboat, The Home Depot, Creative services, Character, Marketing, Collection, House, BEHR, Paralysis, Behr

“Our 2024 Exterior Stain Colour of the Year provides a new perspective on colour for exterior wood stains, adding both character and freshness to projects,” said Erika Woelfel, Vice President of Colour and Creative Services at Behr.

Key Points: 
  • “Our 2024 Exterior Stain Colour of the Year provides a new perspective on colour for exterior wood stains, adding both character and freshness to projects,” said Erika Woelfel, Vice President of Colour and Creative Services at Behr.
  • “With a timeless finish, Tugboat’s versatile brownish grey colour provides organic beauty to make any outdoor space feel like a safe harbour.”
    Behr’s Exterior Stain Colour of the Year headlines the brand’s first-ever Curb Appeal Collection, a curated set of 30 go-to exterior paint, exterior stain and spray paint colours to support consumer confidence during the colour selection process.
  • Behr’s Exterior Stain Colour of the Year and Curb Appeal Collection work in tandem to solve one of consumers’ biggest painting pain points, as many DIYers struggle with colour paralysis when selecting hues, particularly for the exterior of their homes.
  • “By offering a collection of curated colours in a diverse product offering, we aim to provide consumers with the confidence they need to select a colour and complete their exterior projects with ease.”
    The 2024 Exterior Stain Colour of the Year is available exclusively at The Home Depot in a variety of BEHR® products, including BEHR PREMIUM® Solid Colour Waterproofing Exterior Stain , as well as BEHR PREMIUM® Semi-Transparent Waterproofing Exterior Stain , BEHR PREMIUM® ADVANCED DECKOVER®, BEHR® Solid Colour House & Fence Wood Stain, and BEHR® DECKPLUS®.

Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes research

Retrieved on: 
금요일, 4월 26, 2024
Biotechnology, Managed Care, Health, General Health, Pharmaceutical, Health Technology, Other Science, Research, Hospitals, Science, Clinical Trials, Diamond, Autoantibody, Cancer, Bangladesh Technical Education Board, Inflammation, Biomedical engineering, National academy, National Academy of Sciences, Mouse, Crohn's disease, Pulmonary hypertension, Map, Science Advances, Vagus nerve stimulation, Inflammatory Bowel Diseases, Diabetes, Interface (computing), Neuroscience, Acetylcholine, Doctor of Philosophy, Spleen, VNS, DRS, Disease, Anatomy, Human, Sensation, Autoimmune disease, Nervous system, Arthritis, Molecular medicine, Physiology, Medicine, Immunology, Medical research, Multimedia, Lupus, Immune system, Antibody, Paralysis, Immunity, Credit, Autoimmunity, Sepsis, Vagus nerve, Vaccine

New research published in Science Advances by The Feinstein Institutes for Medical Research scientists shows that activation of the vagus nerve triggers the spleen, thereby regulating the production of antibodies.

Key Points: 
  • New research published in Science Advances by The Feinstein Institutes for Medical Research scientists shows that activation of the vagus nerve triggers the spleen, thereby regulating the production of antibodies.
  • This research highlights how the nervous system regulates immunity and suggests potential for non-pharmalogical, vagus nerve modulation to treat a variety of diseases, like lupus and sepsis.
  • Dr. Zanos’s research focus is on understanding the anatomy and physiology of the vagus nerve and the effects vagus nerve stimulation has in inflammation and cardiovascular diseases.
  • At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Demystifying Acupuncture: Modern Answers About Ancient Medicine Offers an Insightful Guide to Understanding the Healing Powers of Acupuncture

Retrieved on: 
화요일, 4월 23, 2024
Book, Amazon, Health, Paralysis, Coffee, Acupuncture, Philosophy, Medicine, History, General surgery

Acupuncturist, medical practitioner and founder of Chicago Healing Center , Dr. Sina Smith , is proud to announce the release of her new book, "Demystifying Acupuncture: Modern Answers About Ancient Medicine."

Key Points: 
  • Acupuncturist, medical practitioner and founder of Chicago Healing Center , Dr. Sina Smith , is proud to announce the release of her new book, "Demystifying Acupuncture: Modern Answers About Ancient Medicine."
  • This insightful guide offers readers a simplistic yet comprehensive understanding of acupuncture and its evidence-based principles that make it a transformative journey to wellness.
  • Whether you are new to acupuncture or seeking to deepen your understanding of this ancient healing modality, "Demystifying Acupuncture" serves as an invaluable resource for anyone interested in holistic healthcare.
  • "Demystifying Acupuncture: Modern Answers About Ancient Medicine" is available at Amazon and anywhere you buy books.

Nonprofit Visions2030 Moves to Counter Climate "Doom Loop" with Lumisphere Experience

Retrieved on: 
월요일, 4월 22, 2024
United Nations, System, Fear, Mentorship, Risk, Imagination, AI, Climate, The arts, Magic, Sphere, Eco-anxiety, Optimism, Consciousness, MOM, Multimedia, Paralysis, Lancet, Tourism

NEW YORK, April 22, 2024 /PRNewswire/ -- Visions2030, a New York City-based nonprofit, announced today a campaign to bring the Lumisphere Experience to communities, entertainment venues, and sites of cultural and international events across the United States and the globe. The campaign aims to conclude in 2030, the target year of the United Nations' Sustainable Development Goals, and is seeking relationships with strategic partners who want to be associated with an innovative initiative that inspires and activates more people to be involved in climate-related topics and issues.

Key Points: 
  • The globe is facing skyrocketing levels of climate anxiety and its paralysis, according to studies.
  • "With climate despair at an all-time high, the need for action is both urgent and overwhelming," says Visions2030 Founder Carey Lovelace.
  • A key metric of the Lumisphere campaign, she says, is to engage millions by 2030, shifting climate conversations, engaging communities, and activating participants.
  • To get involved with or learn more about the Lumisphere and the campaign, please visit www.visions2030.studio or email [email protected] .

Behr Paint Company Announces 2024 Exterior Stain Color of the Year, "Tugboat," Part of its New Curb Appeal Collection

Retrieved on: 
화요일, 4월 16, 2024
Tugboat, The Home Depot, Creative services, Character, Marketing, Collection, House, BEHR, Paralysis, Behr, Paint

SANTA ANA, Calif., April 16, 2024 /PRNewswire/ -- Today, Behr Paint Company debuts its 2024 Exterior Stain Color of the Year: Tugboat, a delicate blend of brown and gray tones offering a timeless finish with a charming nautical appeal suited to ease into any design style. The versatile stain color enhances the natural beauty of wood grain, while providing protection on exterior surfaces that will not only elevate the aesthetic of outdoor spaces but stand the test of time.

Key Points: 
  • SANTA ANA, Calif., April 16, 2024 /PRNewswire/ -- Today, Behr Paint Company debuts its 2024 Exterior Stain Color of the Year: Tugboat, a delicate blend of brown and gray tones offering a timeless finish with a charming nautical appeal suited to ease into any design style.
  • "Our 2024 Exterior Stain Color of the Year provides a new perspective on color for exterior wood stains, adding both character and freshness to projects," said Erika Woelfel, Vice President of Color and Creative Services at Behr.
  • Behr's Exterior Stain Color of the Year headlines the brand's first-ever Curb Appeal Collection, a curated set of 30 go-to exterior paint, exterior stain, and spray paint colors to support consumer confidence during the color selection process.
  • The 2024 Exterior Stain Color of the Year is available exclusively at The Home Depot in a variety of BEHR® products including the #1 rated exterior stain, according to a leading independent consumer publication, BEHR PREMIUM® Solid Color Premium Waterproofing Exterior Stain , as well as BEHR PREMIUM® Semi-Transparent Waterproofing Exterior Stain , BEHR PREMIUM® ADVANCED DECKOVER®, BEHR® Solid Color House & Fence Wood Stain, and BEHR® DECKPLUS®.

Orphan designation: branaplam Treatment of spinal muscular atrophy, 16/04/2018 Withdrawn

Retrieved on: 
목요일, 4월 18, 2024
Eurostat, Diagnosis, Civil service commission, SMN, Brain, Atrophy, Gene, Weakness, Spinal muscular atrophy, Survival, Medicine, Disease, Paralysis, Novartis, Patient, Committee, Knowledge, Ventilation, Regulation, Brain cell, EMA, IRIS, Mouth, European, COMP, Spinal cord, Sponsor, European Commission, Spine, Safety, SMN1, Marketing, SMN2, Pharmaceutical industry

Orphan designation: branaplam Treatment of spinal muscular atrophy, 16/04/2018 Withdrawn

Key Points: 


Orphan designation: branaplam Treatment of spinal muscular atrophy, 16/04/2018 Withdrawn

Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer

Retrieved on: 
월요일, 4월 8, 2024
Speech, GSK plc, Dexcom, ALS, Paralysis, Diabetes, Patient, Conditional sentence, Instrument, Heel, Electronics, Research, Otis, News, University, Computer engineering, Electricity, G7, Precision, FDA, Movement, Medical device

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer.
  • He was one of the co-founders of Verily, Alphabet Inc.’s healthcare and life sciences company, where he served as Chief Technical Officer and Fellow from 2015 through 2022.
  • He oversaw a large, multidisciplinary team in the end-to-end development of new medical technology, from discovery to manufacturing.
  • Under Otis’ technical leadership, Verily entered a number of significant collaborations with leading healthcare and pharmaceutical partners.